AlphaYouCTSO: Chan Phillip P. discloses a purchase
By AlphaYouPublished Form 4
Chan Phillip P.
Reporting filer
Chan Phillip P. reported Purchase in Cytosorbents Corp: 3774 units of Common Stock, dated 2026-09-15. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 16, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Chan Phillip P. | 2026-09-15 | P | Purchase | 3774 | 6.00 | 100,996 | 1 day | Filed terms
|
Common Stock
- Owner
- Chan Phillip P.
- Date
- 2026-09-15
- Code
- P
- Action
- Purchase
- Quantity
- 3774
- Price
- 6.00
- Following holdings
- 100,996
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-15
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 3774
- id: F1
- transaction Price Per Share: 6.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 100996
- id: F2
- id: F3
- id: F4
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Chan Phillip P.: Chief Executive Officer, Director.
- F1: This transaction reported on this Form 4 reflects an open market purchase made by the Reporting Person.
- F2: Includes: (i) the following restricted stock units ("RSUs") that will be settled into shares of Common Stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Issuer") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 515 RSUs granted on March 15, 2018, (b) 935 RSUs granted on February 24, 2017, (c) 2,850 RSUs granted on June 7, 2016 and (d) 6,500 RSUs granted on April 8, 2015;
- F3: (continued from footnote 2) (ii) 2,640 RSUs of 5,280 granted on August 8, 2025, which vest in equal parts at the first and second year anniversaries of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date, and (iii) 83,782 shares of Common Stock owned by the Reporting Person.
- F4: Reflects the 1-for-20 reverse stock split effected by the Issuer on September 8, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.